Concepedia

J. Kent Barbay

JK

Statistics

Publications

16

Citations

551

H-Index

12

Active since

1998

Affiliations

Johnson & Johnson (United States)(Current)

Janssen (United States)

Springhouse

Harvard University

J. Kent Barbay is an author at Johnson & Johnson (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1998–2021

16

Publications

16

Asymmetric Synthesis of Chiral Organofluorine Compounds:  Use of Nonracemic Fluoroiodoacetic Acid as a Practical Electrophile and Its Application to the Synthesis of Monofluoro Hydroxyethylene Dipeptide Isosteres within a Novel Series of HIV Protease Inhibitors

Andrew G. Myers, J. Kent Barbay, Boyu Zhong · Journal of the American Chemical Society · 2001 · 140 citations

, , +11

Identification of GAPDH as a protein target of the saframycin antiproliferative agents

Chengguo Xing, Jacob R. LaPorte, J. Kent Barbay et al. · Proceedings of the National Academy of Sciences · 2004 · 76 citations · Full text

, , +13

On the Inherent Instability of α-Amino α‘-Fluoro Ketones. Evidence for Their Transformation to Reactive Oxyvinyliminium Ion Intermediates

Andrew G. Myers, J. Kent Barbay · Organic Letters · 2001 · 55 citations

, , +10

Design and Characterization of Optimized Adenosine A<sub>2A</sub>/A<sub>1</sub> Receptor Antagonists for the Treatment of Parkinson's Disease

Brian C. Shook, Stefanie Rassnick, Nathaniel Wallace et al. · Journal of Medicinal Chemistry · 2012 · 46 citations · Full text

, , +12

Synthesis and Biological Evaluation of Novel Pyridazinone-Based α<sub>4</sub>Integrin Receptor Antagonists

Yong Gong, J. Kent Barbay, Alexey B. Dyatkin et al. · Journal of Medicinal Chemistry · 2006 · 38 citations · Full text

, , +17

1–5 of 16